Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs

Drugs

  • ADHD (63)
  • Anxiety (25)
  • Bipolar Disorder (15)
  • Depression (214)
    • Cardiovascular Disease and Depression (4)
    • Drugs (190)
      • Atypical Antipsychotics (55)
      • Benzodiazepines (40)
      • Bupropion (44)
      • MAOIs (14)
      • SNRIs (82)
      • SSRIs (94)
      • TCAs (38)
      • Typical Antipsychotics (4)
    • Natural Medicines/Supplements (12)
    • Pediatrics (15)
    • Post-Traumatic Stress Disorder (8)
    • Pregnancy (8)
    • Seasonal Affective Disorder (7)
    • Treatment-Resistant Depression (17)
  • Mental Health (22)
  • Resources (127)
  • Schizophrenia (55)
  • Sleep Disorders (84)
  • Substance Use Disorder (221)
136 - 150 of 190 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: QT Prolongation, Torsades de Pointes, & Medication Safety September 2011
Article: stronger warnings about Seroquel (quetiapine) and "QT prolongation" heart problems September 2011
Article: new warnings about Chantix and an increased risk of heart troubles in patients with heart disease August 2011
Patient Education: Safe Use of Acetaminophen (Tylenol) August 2011
Commentary: Chantix (Varenicline): New Safety Information and Instructions For Use August 2011
Commentary: Chantix (Varenicline) and Risk of Cardiovascular Events August 2011
Guideline: Treating Tobacco Use and Dependence (2008 Update) August 2011
Article: Viibryd (VI-brid, vilazodone), a new "dual-acting" antidepressant July 2011
Article: whether it's okay to combine certain antidepressants July 2011
Guideline: Practice Guideline for the Treatment of Patients with Major Depressive Disorder (2010) July 2011
Commentary: New Drug: Viibryd (Vilazodone) July 2011
Article: keep all the meds for bipolar disorder straight June 2011
Guideline: Management of Bipolar Disorder in Adults (BD) (2010) June 2011
Article: the safety of meds in pregnancy April 2011
Article: avoid mix-ups with "benzodiazepines" April 2011
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved